Influence of diabetes mellitus interactions with cardiovascular risk factors on post-myocardial infarction heart failure hospitalizations

被引:4
|
作者
Yandrapalli, Srikanth [1 ]
Malik, Aaqib H. [2 ,3 ]
Namrata, Fnu [2 ,3 ]
Pemmasani, Gayatri [4 ]
Bandyopadhyay, Dhrubajyoti [2 ,3 ]
Vallabhajosyula, Saraschandra [5 ]
Aronow, Wilbert S. [2 ,3 ]
Frishman, William H. [3 ,6 ]
Jain, Diwakar [2 ,3 ]
Cooper, Howard A. [2 ,3 ]
Panza, Julio A. [2 ,3 ]
机构
[1] Harvard Med Sch, Div Cardiol, Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Westchester Med Ctr, Dept Cardiol, Valhalla, NY USA
[3] New York Med Coll, Valhalla, NY 10595 USA
[4] SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA
[5] Wake Forest Univ, Bowman Gray Sch Med, Sect Cardiol, Winston Salem, NC USA
[6] Westchester Med Ctr, Dept Med, Valhalla, NY USA
关键词
Acute myocardial infarction; Diabetes mellitus; Heart failure; Risk factors; Outcomes; NONINSULIN ANTIHYPERGLYCEMIC DRUGS; MYOCARDIAL-INFARCTION; OUTCOMES; IMPACT; MORTALITY; BENEFITS; INSULIN; SAFETY;
D O I
10.1016/j.ijcard.2021.11.086
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: There is a paucity of information regarding how cardiovascular risk factors (RF) modulate the impact of diabetes mellitus (DM) on the heart failure hospitalization (HFH) risk following an acute myocardial infarction (AMI). Methods: Adult survivors of an AMI were retrospectively identified from the 2014 US Nationwide Readmissions Database. The impact of DM on the risk for a 6-month HFH was studied in subgroups of RFs using multivariable logistic regression to adjust for baseline risk differences. Individual interactions of DM with RFs were tested. Results: Of 237,549 AMI survivors, 37.2% patients had DM. Primary outcome occurred in 12,934 patients (5.4%), at a 106% higher rate in DM patients (7.9% vs 4.0%, p < 0.001), which was attenuated to a 45% higher adjusted risk. Higher HFH risk in DM patients was consistent across subgroups and significant interactions were present between DM and other RFs. The increased HFH risk with DM was more pronounced in patients without certain HF RFs compared with those with these RFs [age < 65: OR for DM 1.84 (1.58-2.13) vs age >= 65: OR 1.34 (1.24-1.45); HF absent during index AMI: OR for DM 1.87 (1.66-2.10) vs HF present: OR 1.24 (1.14-1.34); atrial fibrillation absent: OR for DM 1.57 (1.46-1.68) vs present: OR 1.19 (1.06-1.33); Pinteraction < 0.001 for all]. Similar results were noted for hypertension and chronic kidney disease. Conclusions: AMI survivors with DM had a higher risk of 6-month HFHs. The impact of DM on the increased HFH risk was more pronounced in patients without certain RFs suggesting that more aggressive preventive strategies related to DM and HF are needed in these subgroups to prevent or delay the onset of HFHs.
引用
收藏
页码:140 / 146
页数:7
相关论文
共 50 条
  • [1] Diabetes mellitus exacerbates post-myocardial infarction heart failure by reducing sarcolipin promoter methylation
    Liu, Zhongwei
    Zhang, Yong
    Qiu, Chuan
    Zhu, Haitao
    Pan, Shuo
    Jia, Hao
    Kang, Hongyan
    Guan, Gongchang
    Hui, Rutai
    Zhu, Ling
    Wang, Junkui
    ESC HEART FAILURE, 2020, 7 (04): : 1935 - 1948
  • [2] Diabetes and heart failure in the post-myocardial infarction patient
    Estep J.D.
    Aguilar D.
    Current Heart Failure Reports, 2006, 3 (4) : 164 - 169
  • [3] Post-Myocardial Infarction Heart Failure
    Bahit, M. Cecilia
    Kochar, Ajar
    Granger, Christopher B.
    JACC-HEART FAILURE, 2018, 6 (03) : 179 - 186
  • [4] The spectrum of post-myocardial infarction care: From acute ischemia to heart failure
    Akhtar, Khawaja Hassan
    Khan, Muhammad Shahzeb
    Baron, Suzanne J.
    Zieroth, Shelley
    Estep, Jerry
    Burkhoff, Daniel
    Butler, Javed
    Fudim, Marat
    PROGRESS IN CARDIOVASCULAR DISEASES, 2024, 82 : 15 - 25
  • [5] Immunopharmacology of Post-Myocardial Infarction and Heart Failure Medications
    Panahi, Mona
    Vadgama, Nimai
    Kuganesan, Mathun
    Ng, Fu Siong
    Sattler, Susanne
    JOURNAL OF CLINICAL MEDICINE, 2018, 7 (11)
  • [6] Natriuretic Peptides in Heart Failure and Post-Myocardial Infarction
    Lijnen, Paul
    Diaz-Araya, Guillermo
    Petrov, Victor
    Fagard, Robert
    CURRENT HYPERTENSION REVIEWS, 2005, 1 (01) : 7 - 13
  • [7] miRNAs emerge as circulating biomarkers of post-myocardial infarction heart failure
    Cruz, Marina Sampaio
    da Silva, Ananilia Medeiros Gomes
    de Souza, Karla Simone Costa
    Luchessi, Andre Ducati
    Silbiger, Vivian Nogueira
    HEART FAILURE REVIEWS, 2020, 25 (02) : 321 - 329
  • [8] The Impact of Post-Myocardial Infarction (MI) Depression on Cardiovascular-Related Hospitalizations
    Henderson, Chloe
    Gillard, Christopher
    Wheeler, Janel Bailey
    Maestri, Thomas
    Smith, Candice
    Olet, Susan
    CURRENT PROBLEMS IN CARDIOLOGY, 2024, 49 (01)
  • [9] Serum lipidomics reveals phosphatidylethanolamine and phosphatidylcholine disorders in patients with myocardial infarction and post-myocardial infarction-heart failure
    Rong, Jidong
    He, Tianmu
    Zhang, Jianyong
    Bai, Zhixun
    Shi, Bei
    LIPIDS IN HEALTH AND DISEASE, 2023, 22 (01)
  • [10] Mitochondrial Aldehyde Dehydrogenase, A Therapeutic Target In Post-myocardial Infarction Heart Failure In Diabetes
    Palaniyandi, Suresh
    Mali, Vishal
    Xu, Jiang
    Yang, Xiao-Ping
    CIRCULATION RESEARCH, 2013, 113 (04)